Feeds › Insider trades
Insider trades
Open-market buys and sells by officers, directors and 10% owners, from SEC Form 4. Usually filed within two business days.
About this data
- What it is
- When a company's officers, directors or owners of more than 10% buy or sell its stock, they must report the trade to the SEC on Form 4. This feed shows purchases and sales on the open market; stock grants, option exercises and shares withheld for tax are left out.
- Who files it
- The insider, usually through the company, within two business days of the trade.
- How current
- We collect new filings throughout the day on SEC business days.
- Worth knowing
- Sales are often routine: insiders sell to diversify, to pay taxes, or under a 10b5-1 plan set up months in advance. A purchase with their own money is less common, which is why many investors pay closer attention to it.
All of this comes from public filings.
Source and freshness · Information, not investment advice (disclaimer).
Open-market trades per day, last 30 days
Purchases Sales
By trade date. Insiders have two business days to file, so the most recent days fill in later.
Latest open-market insider trades
Showing: ticker VIR
| Traded | Insider | Company | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Nov 3, 2026 | Vanina de Verneuil EVP, General Counsel, Corp Sec | VIR Vir Biotechnology, Inc. | Sale | 2,407 | $11.10 | $26.7K Sale | Form 4 ↗ |
| Nov 2, 2026 | Vanina de Verneuil EVP, General Counsel, Corp Sec | VIR Vir Biotechnology, Inc. | Sale | 1,343 | $11.33 | $15.2K Sale | Form 4 ↗ |
| Jun 1, 2026 | Janet Napolitano Director | VIR Vir Biotechnology, Inc. | Sale | 3,200 | $9.45 | $30.2K Sale | Form 4 ↗ |
| Jun 1, 2026 | Brent Sabatini SVP, Chief Accounting Officer | VIR Vir Biotechnology, Inc. | Sale | 379 | $9.45 | $3,582 Sale | Form 4 ↗ |
| May 1, 2026 | Vicki L. Sato Director | VIR Vir Biotechnology, Inc. | Sale | 22,000 | $10.05 | $221.1K Sale | Form 4 ↗ |
| Apr 6, 2026 | Marianne De Backer President and CEO, Director | VIR Vir Biotechnology, Inc. | Sale | 72,559 | $9.16 | $664.6K Sale | Form 4 ↗ |
| Apr 1, 2026 | Vicki L. Sato Director | VIR Vir Biotechnology, Inc. | Sale | 22,000 | $9.07 | $199.5K Sale | Form 4 ↗ |
| Mar 23, 2026 | Brent Sabatini SVP, Chief Accounting Officer | VIR Vir Biotechnology, Inc. | Sale | 7,711 | $9.12 | $70.3K Sale | Form 4 ↗ |
| Mar 2, 2026 | Vicki L. Sato Director | VIR Vir Biotechnology, Inc. | Sale | 200 | $9.98 | $1,996 Sale | Form 4 ↗ |
| Mar 2, 2026 | Vicki L. Sato Director | VIR Vir Biotechnology, Inc. | Sale | 21,800 | $9.50 | $207.1K Sale | Form 4 ↗ |
| Feb 25, 2026 | Mark Eisner EVP and Chief Medical Officer | VIR Vir Biotechnology, Inc. | Sale | 1,889 | $9.82 | $18.5K Sale | Form 4 ↗ |
| Feb 25, 2026 | Vanina de Verneuil EVP, General Counsel, Corp Sec | VIR Vir Biotechnology, Inc. | Sale | 13,700 | $9.82 | $134.5K Sale | Form 4 ↗ |
| Feb 24, 2026 | Vicki L. Sato Director | VIR Vir Biotechnology, Inc. | Sale | 200 | $10.26 | $2,052 Sale | Form 4 ↗ |
| Feb 24, 2026 | Vicki L. Sato Director | VIR Vir Biotechnology, Inc. | Sale | 42,177 | $9.75 | $411.2K Sale | Form 4 ↗ |
| Feb 24, 2026 | Brent Sabatini SVP, Chief Accounting Officer | VIR Vir Biotechnology, Inc. | Sale | 1,430 | $9.53 | $13.6K Sale | Form 4 ↗ |
| Feb 24, 2026 | Jason O'Byrne EVP & Chief Financial Officer | VIR Vir Biotechnology, Inc. | Sale | 1,634 | $9.53 | $15.6K Sale | Form 4 ↗ |
| Feb 24, 2026 | Mark Eisner EVP and Chief Medical Officer | VIR Vir Biotechnology, Inc. | Sale | 1,616 | $9.53 | $15.4K Sale | Form 4 ↗ |
| Feb 24, 2026 | Vanina de Verneuil EVP, General Counsel, Corp Sec | VIR Vir Biotechnology, Inc. | Sale | 3,117 | $9.53 | $29.7K Sale | Form 4 ↗ |
| Feb 24, 2026 | Marianne De Backer Chief Executive Officer, Director | VIR Vir Biotechnology, Inc. | Sale | 14,762 | $9.53 | $140.7K Sale | Form 4 ↗ |
| Feb 23, 2026 | Brent Sabatini SVP, Chief Accounting Officer | VIR Vir Biotechnology, Inc. | Sale | 1,829 | $7.45 | $13.6K Sale | Form 4 ↗ |
| Feb 23, 2026 | Jason O'Byrne EVP & Chief Financial Officer | VIR Vir Biotechnology, Inc. | Sale | 2,089 | $7.45 | $15.6K Sale | Form 4 ↗ |
| Feb 23, 2026 | Mark Eisner EVP and Chief Medical Officer | VIR Vir Biotechnology, Inc. | Sale | 2,089 | $7.45 | $15.6K Sale | Form 4 ↗ |
| Feb 23, 2026 | Vanina de Verneuil EVP, General Counsel, Corp Sec | VIR Vir Biotechnology, Inc. | Sale | 4,445 | $7.45 | $33.1K Sale | Form 4 ↗ |
| Feb 23, 2026 | Marianne De Backer Chief Executive Officer, Director | VIR Vir Biotechnology, Inc. | Sale | 19,039 | $7.45 | $141.8K Sale | Form 4 ↗ |
| Feb 13, 2026 | Brent Sabatini SVP, Chief Accounting Officer | VIR Vir Biotechnology, Inc. | Sale | 1,530 | $7.79 | $11.9K Sale | Form 4 ↗ |
| Feb 2, 2026 | Vicki L. Sato Director | VIR Vir Biotechnology, Inc. | Sale | 22,000 | $7.71 | $169.6K Sale | Form 4 ↗ |
| Jan 2, 2026 | Vicki L. Sato Director | VIR Vir Biotechnology, Inc. | Sale | 22,000 | $5.93 | $130.5K Sale | Form 4 ↗ |
| Dec 1, 2025 | Vicki L. Sato Director | VIR Vir Biotechnology, Inc. | Sale | 22,000 | $6.00 | $132.0K Sale | Form 4 ↗ |
| Dec 1, 2025 | SVF Endurance (Cayman) Ltd 10% owner | VIR Vir Biotechnology, Inc. | Sale | 191,854 | $5.98 | $1.1M Sale | Form 4 ↗ |
| Nov 28, 2025 | SoftBank Vision Fund (Aiv M1) L.P. 10% owner | VIR Vir Biotechnology, Inc. | Sale | 61,493 | $6.44 | $396.0K Sale | Form 4 ↗ |
| Nov 26, 2025 | SoftBank Vision Fund (Aiv M1) L.P. 10% owner | VIR Vir Biotechnology, Inc. | Sale | 127,938 | $6.39 | $817.5K Sale | Form 4 ↗ |
| Nov 25, 2025 | SVF Endurance (Cayman) Ltd 10% owner | VIR Vir Biotechnology, Inc. | Sale | 235,971 | $6.38 | $1.5M Sale | Form 4 ↗ |
| Nov 24, 2025 | SVF Endurance (Cayman) Ltd 10% owner | VIR Vir Biotechnology, Inc. | Sale | 227,803 | $6.15 | $1.4M Sale | Form 4 ↗ |
| Nov 17, 2025 | Jason O'Byrne EVP & Chief Financial Officer | VIR Vir Biotechnology, Inc. | Sale | 6,799 | $5.56 | $37.8K Sale | Form 4 ↗ |
| Nov 5, 2025 | Vanina de Verneuil EVP, General Counsel, Corp Sec | VIR Vir Biotechnology, Inc. | Sale | 2,385 | $5.16 | $12.3K Sale | Form 4 ↗ |
| Nov 3, 2025 | Vanina de Verneuil EVP and General Counsel | VIR Vir Biotechnology, Inc. | Sale | 1,365 | $5.86 | $7,999 Sale | Form 4 ↗ |
| Nov 3, 2025 | Vicki L. Sato Director | VIR Vir Biotechnology, Inc. | Sale | 22,000 | $5.64 | $124.1K Sale | Form 4 ↗ |
| Oct 29, 2025 | SVF Endurance (Cayman) Ltd 10% owner | VIR Vir Biotechnology, Inc. | Sale | 100 | $6.49 | $649 Sale | Form 4 ↗ |
| Oct 28, 2025 | SVF Endurance (Cayman) Ltd 10% owner | VIR Vir Biotechnology, Inc. | Sale | 24,453 | $6.50 | $158.9K Sale | Form 4 ↗ |
| Oct 27, 2025 | SB Investment Advisers (UK) Ltd 10% owner | VIR Vir Biotechnology, Inc. | Sale | 66,403 | $6.05 | $401.7K Sale | Form 4 ↗ |
| Oct 24, 2025 | SB Investment Advisers (UK) Ltd 10% owner | VIR Vir Biotechnology, Inc. | Sale | 46,696 | $5.96 | $278.3K Sale | Form 4 ↗ |
| Oct 23, 2025 | SB Investment Advisers (UK) Ltd 10% owner | VIR Vir Biotechnology, Inc. | Sale | 154,383 | $5.99 | $924.8K Sale | Form 4 ↗ |
| Oct 22, 2025 | SB Investment Advisers (UK) Ltd 10% owner | VIR Vir Biotechnology, Inc. | Sale | 144,266 | $6.15 | $887.2K Sale | Form 4 ↗ |
| Oct 21, 2025 | SVF Endurance (Cayman) Ltd 10% owner | VIR Vir Biotechnology, Inc. | Sale | 109,675 | $6.30 | $691.0K Sale | Form 4 ↗ |
| Oct 20, 2025 | SVF Endurance (Cayman) Ltd 10% owner | VIR Vir Biotechnology, Inc. | Sale | 220,535 | $6.20 | $1.4M Sale | Form 4 ↗ |
| Oct 16, 2025 | SVF Endurance (Cayman) Ltd 10% owner | VIR Vir Biotechnology, Inc. | Sale | 12,844 | $6.10 | $78.3K Sale | Form 4 ↗ |
| Oct 15, 2025 | SVF Endurance (Cayman) Ltd 10% owner | VIR Vir Biotechnology, Inc. | Sale | 16,671 | $6.07 | $101.2K Sale | Form 4 ↗ |
| Oct 10, 2025 | SoftBank Vision Fund (Aiv M1) L.P. 10% owner | VIR Vir Biotechnology, Inc. | Sale | 2,300 | $6.08 | $14.0K Sale | Form 4 ↗ |
| Oct 9, 2025 | SoftBank Vision Fund (Aiv M1) L.P. 10% owner | VIR Vir Biotechnology, Inc. | Sale | 249,060 | $6.14 | $1.5M Sale | Form 4 ↗ |
| Oct 8, 2025 | SB Investment Advisers (UK) Ltd 10% owner | VIR Vir Biotechnology, Inc. | Sale | 466,242 | $6.05 | $2.8M Sale | Form 4 ↗ |
The newest 50 items, most recent first. Every row links to its original filing. Updated Nov 15, 2026, 5:59 PM EST.
Download CSV The rows of this feed, with the filters above. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.
Other feeds: Congressional trades · Executive-branch trades · Bills in Congress · Roll-call votes · Corporate PAC donations · Lobbying · Capitol Hires · Lobbying and contracts · Government contracts · Planned insider sales · Executive pay · Ownership stakes (13D / 13G) · Institutional holdings (13F) · Short interest · Fails to deliver · Daily short volume · Wikipedia page views · App store ratings · H-1B visa applications · Stock splits · 8-K events · IPO filings · Deals · Private placements (Form D) · Merger clearances (HSR) · Layoff notices (WARN) · SEC enforcement · Patents · Clinical trial updates · FDA approvals and clearances